Current role
Christopher Freeman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher Freeman
The proxy statement of Guardant Health, Inc. reports total compensation of $3,523,052 for Christopher Freeman in fiscal 2023, including a base salary of $490,385. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Guardant Health, Inc. (GH)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Guardant Health, Inc.
Other people whose current roles at this company are on record from its filings.
- AmirAli Talasaz CEO, Board Member
- Helmy Eltoukhy CEO, Chairman, Board Member
- Michael Bell CFO
- Ines Dahne-Steuber COO
- Darya Chudova CTO
- Kumud Kalia CIO
- John Saia General Counsel
- Alex M. Azar II Board Member
- Ian Clark Board Member
- Manuel Hidalgo Medina Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Guardant Health, Inc. (GH) | Chief Commercial Officer | $490,385 | $3,523,052 |
| 2022 | Guardant Health, Inc. (GH) | Chief Commercial Officer | $468,269 | $3,969,567 |
| 2021 | Guardant Health, Inc. (GH) | Chief Commercial Officer | $249,231 | $5,436,449 |
Recent activity
No call appearances or filed executive changes recorded yet.